Divis Laboratories Ltd (DIVISLAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Divis Laboratories Ltd reported sales of ₹3,080 Cr, operating profit of ₹1,255 Cr (OPM 41%) and net profit of ₹902 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
DIVISLAB quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 2,338 2,319 2,585 2,410 2,715 2,604 2,831 3,080 Expenses 1,622 1,576 1,699 1,681 1,827 1,714 1,897 1,825 Operating Profit 716 743 886 729 888 890 934 1,255 OPM 31% 32% 34% 30% 33% 34% 33% 41% Other Income 106 82 86 119 145 14 155 64 Interest 1 0 1 3 8 6 6 6 Depreciation 99 99 107 112 113 118 120 133 Profit before tax 722 726 864 733 912 780 963 1,180 Tax 29% 19% 23% 26% 24% 25% 22% 24% Net Profit 510 589 662 545 689 583 751 902 EPS in Rs 19.21 22.19 24.94 20.53 25.95 21.96 28.29 33.98
DIVISLAB profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 8,960 7,768 7,845 9,360 10,560 11,230 Expenses 5,075 5,397 5,635 6,387 7,118 7,263 Operating Profit 3,885 2,370 2,210 2,973 3,442 3,967 OPM 43% 31% 28% 32% 33% 35% Other Income 112 344 335 348 433 378 Interest 2 2 4 3 24 26 Depreciation 312 343 378 402 463 484 Profit before tax 3,684 2,369 2,163 2,916 3,388 3,835 Tax 20% 23% 26% 25% 24% - Net Profit 2,960 1,823 1,600 2,191 2,568 2,925 EPS in Rs 111.52 68.69 60.27 82.53 96.73 110.18 Dividend Payout 27% 44% 50% 36% 31% -
DIVISLAB balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 53 53 53 53 53 Reserves 12,714 13,518 14,916 15,360 16,708 Borrowings 3 3 4 90 7 Other Liabilities 1,654 1,886 1,948 2,648 3,251 Total Liabilities 14,425 15,460 16,921 18,151 20,019 Fixed Assets 4,723 4,739 5,442 5,678 6,528 CWIP 212 778 1,022 2,030 2,113 Investments 77 82 65 67 69 Other Assets 9,413 9,861 10,392 10,376 11,309 Total Assets 14,425 15,460 16,921 18,151 20,019
DIVISLAB cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 1,912 2,460 1,261 1,653 2,738 Cash from Investing Activity -2,195 -2,708 -269 -804 -2,219 Cash from Financing Activity -532 -797 -799 -799 -804 Net Cash Flow -816 -1,045 193 50 -285 Free Cash Flow 1,199 1,987 258 215 221 CFO/OP 66% 124% 74% 83% 105%
DIVISLAB ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 99 84 100 106 103 Inventory Days 341 352 364 311 346 Days Payable 96 89 94 88 106 Cash Conversion Cycle 344 347 370 330 343 Working Capital Days 177 188 206 192 195 ROCE 35% 19% 16% 20% 22%